193 related articles for article (PubMed ID: 33675810)
21. Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel Disease.
Walker GJ; Harrison JW; Heap GA; Voskuil MD; Andersen V; Anderson CA; Ananthakrishnan AN; Barrett JC; Beaugerie L; Bewshea CM; Cole AT; Cummings FR; Daly MJ; Ellul P; Fedorak RN; Festen EAM; Florin TH; Gaya DR; Halfvarson J; Hart AL; Heerasing NM; Hendy P; Irving PM; Jones SE; Koskela J; Lindsay JO; Mansfield JC; McGovern D; Parkes M; Pollok RCG; Ramakrishnan S; Rampton DS; Rivas MA; Russell RK; Schultz M; Sebastian S; Seksik P; Singh A; So K; Sokol H; Subramaniam K; Todd A; Annese V; Weersma RK; Xavier R; Ward R; Weedon MN; Goodhand JR; Kennedy NA; Ahmad T;
JAMA; 2019 Feb; 321(8):773-785. PubMed ID: 30806694
[TBL] [Abstract][Full Text] [Related]
22. NUDT15 variant is the most common variant associated with thiopurine-induced early leukopenia and alopecia in Korean pediatric patients with Crohn's disease.
Lee YJ; Hwang EH; Park JH; Shin JH; Kang B; Kim SY
Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):475-8. PubMed ID: 26735160
[TBL] [Abstract][Full Text] [Related]
23. Genotyping NUDT15*3 rs1166855232 reveals higher frequency of potential adverse effects of thiopurines in Natives and Mestizos from Mexico.
Texis T; Guzmán-Cruz C; Rodríguez-Dorantes M; Sánchez-García S; Mino-León D; Gonzalez-Covarrubias V
Pharmacol Rep; 2022 Feb; 74(1):257-262. PubMed ID: 34091879
[TBL] [Abstract][Full Text] [Related]
24. Combined Detection of NUDT15 Variants Could Highly Predict Thiopurine-induced Leukopenia in Chinese Patients with Inflammatory Bowel Disease: A Multicenter Analysis.
Chao K; Wang X; Cao Q; Qian J; Wu K; Zhu X; Yang H; Liang J; Lin L; Huang Z; Zhang Y; Huang Y; Sun Y; Xue X; Huang M; Hu P; Lan P; Gao X
Inflamm Bowel Dis; 2017 Sep; 23(9):1592-1599. PubMed ID: 28570428
[TBL] [Abstract][Full Text] [Related]
25. Homozygote CRIM1 variant is associated with thiopurine-induced neutropenia in leukemic patients with both wildtype NUDT15 and TPMT.
Park Y; Kim H; Seo H; Choi JY; Ma Y; Yun S; Min BJ; Seo ME; Yoo KH; Kang HJ; Im HJ; Kim JH
J Transl Med; 2020 Jul; 18(1):265. PubMed ID: 32611418
[TBL] [Abstract][Full Text] [Related]
26. Nudix hydrolase 15 (NUDT15) loss-of-function variants in an Australian inflammatory bowel disease population.
Afrin S; Simms LA; Lord A; Radford-Smith GL
Intern Med J; 2022 Nov; 52(11):1971-1977. PubMed ID: 35289057
[TBL] [Abstract][Full Text] [Related]
27. The Role of TPMT, ITPA, and NUDT15 Variants during Mercaptopurine Treatment of Swedish Pediatric Patients with Acute Lymphoblastic Leukemia.
Wahlund M; Nilsson A; Kahlin AZ; Broliden K; Myrberg IH; Appell ML; Berggren A
J Pediatr; 2020 Jan; 216():150-157.e1. PubMed ID: 31635813
[TBL] [Abstract][Full Text] [Related]
28. Further evidence that a variant of the gene NUDT15 may be an important predictor of azathioprine-induced toxicity in Chinese subjects: a case report.
Ailing Z; Jing Y; Jingli L; Yun X; Xiaojian Z
J Clin Pharm Ther; 2016 Oct; 41(5):572-4. PubMed ID: 27381176
[TBL] [Abstract][Full Text] [Related]
29. Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update.
Relling MV; Schwab M; Whirl-Carrillo M; Suarez-Kurtz G; Pui CH; Stein CM; Moyer AM; Evans WE; Klein TE; Antillon-Klussmann FG; Caudle KE; Kato M; Yeoh AEJ; Schmiegelow K; Yang JJ
Clin Pharmacol Ther; 2019 May; 105(5):1095-1105. PubMed ID: 30447069
[TBL] [Abstract][Full Text] [Related]
30. Pharmacogenomics of thiopurines: distribution of TPMT and NUDT15 polymorphisms in the Brazilian Amazon.
Ferreira GMA; Ribeiro Elias AB; Nascimento J; Monteiro WM; Melo GC; Baia-da-Silva DC; Lacerda MVG; Suarez-Kurtz G
Pharmacogenet Genomics; 2020 Oct; 30(8):184-189. PubMed ID: 32453263
[TBL] [Abstract][Full Text] [Related]
31. NUDT15 and TPMT genetic polymorphisms are related to 6-mercaptopurine intolerance in children treated for acute lymphoblastic leukemia at the Children's Cancer Center of Lebanon.
Zgheib NK; Akika R; Mahfouz R; Aridi CA; Ghanem KM; Saab R; Abboud MR; Tarek N; El Solh H; Muwakkit SA
Pediatr Blood Cancer; 2017 Jan; 64(1):146-150. PubMed ID: 27577869
[TBL] [Abstract][Full Text] [Related]
32. NUDT15 gene variants and thiopurine-induced leukopenia in patients with inflammatory bowel disease.
Matsuoka K
Intest Res; 2020 Jul; 18(3):275-281. PubMed ID: 32482022
[TBL] [Abstract][Full Text] [Related]
33. Interplay between IL6 and CRIM1 in thiopurine intolerance due to hematological toxicity in leukemic patients with wild-type NUDT15 and TPMT.
Kim H; You S; Park Y; Choi JY; Ma Y; Hong KT; Koh KN; Yun S; Lee KH; Shin HY; Lee S; Yoo KH; Im HJ; Kang HJ; Kim JH
Sci Rep; 2021 May; 11(1):9676. PubMed ID: 33958640
[TBL] [Abstract][Full Text] [Related]
34. NUDT15 genotype distributions in the Korean population.
Kim HT; Choi R; Won HH; Choe YH; Kang B; Lee K; Koo HH; Yoo KH; Kim YH; Lee SY
Pharmacogenet Genomics; 2017 May; 27(5):197-200. PubMed ID: 28277331
[TBL] [Abstract][Full Text] [Related]
35. The c.415C>T polymorphism in NUDT15 is more frequent than the polymorphisms in TPMT in Chilean patients who use thiopurine drugs.
von Muhlenbrock C; Estay C; Covarrubias N; Miranda J; Venegas M
Pharmacogenet Genomics; 2023 Sep; 33(7):161-163. PubMed ID: 37556121
[TBL] [Abstract][Full Text] [Related]
36. Azathioprine dose tailoring based on pharmacogenetic information: Insights of clinical implementation.
Díaz-Villamarín X; Fernández-Varón E; Rojas Romero MC; Callejas-Rubio JL; Cabeza-Barrera J; Rodríguez-Nogales A; Gálvez J; Morón R
Biomed Pharmacother; 2023 Dec; 168():115706. PubMed ID: 37857254
[TBL] [Abstract][Full Text] [Related]
37. NUDT15 codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: a multicenter study.
Kakuta Y; Kawai Y; Okamoto D; Takagawa T; Ikeya K; Sakuraba H; Nishida A; Nakagawa S; Miura M; Toyonaga T; Onodera K; Shinozaki M; Ishiguro Y; Mizuno S; Takahara M; Yanai S; Hokari R; Nakagawa T; Araki H; Motoya S; Naito T; Moroi R; Shiga H; Endo K; Kobayashi T; Naganuma M; Hiraoka S; Matsumoto T; Nakamura S; Nakase H; Hisamatsu T; Sasaki M; Hanai H; Andoh A; Nagasaki M; Kinouchi Y; Shimosegawa T; Masamune A; Suzuki Y;
J Gastroenterol; 2018 Sep; 53(9):1065-1078. PubMed ID: 29923122
[TBL] [Abstract][Full Text] [Related]
38. Optimal predictor for 6-mercaptopurine intolerance in Chinese children with acute lymphoblastic leukemia: NUDT15, TPMT, or ITPA genetic variants?
Zhou H; Li L; Yang P; Yang L; Zheng JE; Zhou Y; Han Y
BMC Cancer; 2018 May; 18(1):516. PubMed ID: 29720126
[TBL] [Abstract][Full Text] [Related]
39. Massively parallel variant characterization identifies
Suiter CC; Moriyama T; Matreyek KA; Yang W; Scaletti ER; Nishii R; Yang W; Hoshitsuki K; Singh M; Trehan A; Parish C; Smith C; Li L; Bhojwani D; Yuen LYP; Li CK; Li CH; Yang YL; Walker GJ; Goodhand JR; Kennedy NA; Klussmann FA; Bhatia S; Relling MV; Kato M; Hori H; Bhatia P; Ahmad T; Yeoh AEJ; Stenmark P; Fowler DM; Yang JJ
Proc Natl Acad Sci U S A; 2020 Mar; 117(10):5394-5401. PubMed ID: 32094176
[TBL] [Abstract][Full Text] [Related]
40. Measurements of 6-thioguanine nucleotide levels with TPMT and NUDT15 genotyping in patients with Crohn's disease.
Lee JH; Kim TJ; Kim ER; Hong SN; Chang DK; Choi LH; Woo HI; Lee SY; Kim YH
PLoS One; 2017; 12(12):e0188925. PubMed ID: 29206869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
